Shawn K. Singh
Overview
Shawn K. Singh received an average of $1M in total compensation, including $492K in salary, at Vistagen Therapeutics from 2015 to 2024.
2024Vistagen TherapeuticsChief Executive Officer
2023Vistagen TherapeuticsChief Executive Officer
2022Vistagen TherapeuticsChief Executive Officer
2020Vistagen TherapeuticsChief Executive Officer
2019Vistagen TherapeuticsChief Executive Officer
2016Vistagen TherapeuticsChief Executive Officer
2015Vistagen TherapeuticsChief Executive Officer
Source: SEC filings on April 15, 2024, July 28, 2023, July 27, 2020, and August 5, 2016.
Related executives
We found seven more executives who work or worked at Vistagen Therapeutics.
Reid Adler
Vistagen Therapeutics
General Counsel
Joshua Prince
Vistagen Therapeutics
Chief Operating Officer
Cynthia Anderson
Vistagen Therapeutics
Chief Financial Officer
Jerrold Dotson
Vistagen Therapeutics
Chief Financial Officer
H Snodgrass
Vistagen Therapeutics
Chief Scientific Officer
Mark Smith
Vistagen Therapeutics
Chief Medical Officer
Mark McPartland
Vistagen Therapeutics